European Primary Care Cardiovascular Society


Adverse pregnancy outcomes reduced with treatment of chronic hypertension

3' education - Apr. 3, 2022 - Prof. Alan Tita, MD, PhD

An algorithm-based program for cardiovascular healthcare

3' education - Nov. 22, 2021 - Alexander J. Blood, MD

Use of non-physician providers to control BP: An ambitious project

3' education - Nov. 14, 2021 - Prof. Keith Ferdinand, MD

Consideration of BP lowering irrespective of prior CVD or baseline SBP

3' education - Sep. 30, 2020 - Kazem Rahimi, MD

Reduced blood pressure and incidence of hypertension with community-wide salt restriction

3' education - Sep. 16, 2019 - Paris, France - Prof. Jaime Miranda

Reduced CV risk with an intervention targeting identified barriers to care

3' education - Sep. 16, 2019 - Paris, France - Prof. J-D Schwalm
EPCCS Annual CV Summit

Recent updates to the international Hypertension Guidelines - where do they vary and what should we agree in primary care?

5' education - Mar. 21, 2019 - Lisbon, Portugal - Richard McManus & Richard Hobbs

ESC/ESH Guidelines on management of hypertension: what's new?

3' education - Feb. 11, 2019 - Prof. Bryan Williams - London, UK


3' education - Feb. 8, 2019

May Measurement Month: Get involved to increase awareness on elevated blood pressure

3' education - Feb. 6, 2019 - Prof. Neil Poulter - London, UK

The cardiovascular challenge for primary care in diabetes

10' education - July 10, 2018 - Prof. Richard Hobbs - Oxford, UK

Hypertension - Can we agree on diagnostic and therapeutic thresholds?

10' education - Mar. 16, 2018 - EPCCS 2018, Barcelona, Spain - Prof. Richard McManus, prof. Richard Hobbs and prof. Christos Lionis

Pharmacist intervention in American 'black barbershops' effective at lowering BP

3' education - Mar. 12, 2018 - ACC 2018, Orlando, FL, USA - Dr. Ronald Victor, MD - Los Angeles, CA, USA

Clinical outcomes and adverse effects comparable across various BP measurement methods in SPRINT

3' education - Nov. 20, 2017 - AHA 2017 - Anaheim, CA, USA - Dr. Sripal Bangalore - NYU Langone, New York, NY, USA.

Good BP measurement depends more on appropriate technique than on absence of staff

3' education - Nov. 25, 2017 - AHA 2017 - Anaheim, CA, USA - Prof Karen Johnson - Memphis, TN, VS

What can be learned from the latest hypertension trials?

10' education - May 26, 2017

Identifying and treating patients with true hypertension

10' education - Feb. 24, 2016 - Prague - EPCCS 2015

Alcohol as a risk factor for hypertension

3' education - Nov. 20, 2014 - Brussels, Belgium - Prof. Daniel Duprez (Minnesota, USA) - EPCCS 2014

Renal denervation for truly resistant hypertension

3' education - Feb. 18, 2014 - London - 5-6 September 2013

What's new in hypertension guidelines?

3' education - Oct. 18, 2013 - EPCCS, September 5-6, 2013 - Richard McManus

What is the best method for diagnosing hypertension?

3' education - Sep. 7, 2012 - EPCCS 2012 - prof Richard McManus

No threshold in the association of alcohol consumption with blood pressure in healthy persons

Literature - Sep. 26, 2023 - Di Federico S, et al. - Hypertension. 2023

In a meta-analysis of 7 nonexperimental cohort studies, there was a positive, almost linear association with no evidence of a threshold between alcohol consumption at baseline and systolic blood pressure levels during follow-up in healthy persons.

Phase 2 study of siRNA targeting angiotensinogen in patients with hypertension meets primary endpoint

News - Sep. 12, 2023

A greater than 15 mmHg reduction in 24-h ambulatory systolic BP was reported with the two highest single doses of the siRNA therapeutic zilebesiran, targeting hepatic angiotensinogen synthesis, at month 3 compared with placebo in the KARDIA 1 phase 2 trial.

2023 ESH Guidelines for management of arterial hypertension

News - Aug. 3, 2023

The 2023 European Society of Hypertension (ESH) guidelines for the management of arterial hypertension has been published.

Substantial variation in SBP response to common antihypertensive drugs

Literature - June 15, 2023 - Sundström J et al. - JAMA. 2023

In the PHYSIC trial, systolic blood pressure (SBP) response to 4 widely used antihypertensive drug classes varied considerably. Personalized treatment had the potential to lower SBP by 4.4 mmHg compared with a fixed drug choice.

Increased prevalence of diabetes and obesity among young US adults

Literature - June 13, 2023 - Aggarwal R, et al. - JAMA. 2023

A serial cross-sectional analysis using data of the NHANES database investigated whether the prevalence of CV risk factors among young US adults changed from 2009 to March 2020.

Associations between TG and cardiometabolic risk factors influenced by ancestral and environmental differences

Literature - June 7, 2023 - Meeks KAC, et al. - EBioMedicine. 2023

An analysis of 32,019 individuals showed stronger associations between triglyceride (TG) levels and hypertension, SBP , BMI, or waist circumference in those of European ancestry compared with West African ancestry with minimal or no influence by environmental context, contrary to the associations with T2DM or fasting glucose.

Effect of optimal risk factor management on recurrent ASCVD risk

Literature - Apr. 4, 2023 - Van Trier TJ, et al. - Eur J Prev Cardiol. 2023

A pooled analysis of patients with established ASCVD showed a 10-year risk of recurrent ASCVD events of 20% and a lifetime risk of 54%. Theoretically, optimization of both lifestyle and medications could reduce both risks and add 7.3 event-free years.

Association between cumulative systolic blood pressure load and cardiovascular events in diabetes

Literature - Jan. 5, 2023 - Wang N et al. - J Am Coll Cardiol. 2022

In a post-hoc analysis of the ADVANCE trial, cumulative SBP load was a better predictor of the occurrence of MACE in patients with T2DM compared with other BP measures.

Antihypertensive treatment associated with lower risk of dementia

Literature - Nov. 21, 2022 - Peters R et al. - Eur Heart J. 2022

In a meta-analysis of pooled individual participant data from 5 double-blind placebo-controlled RCTs, antihypertensive treatment was associated with a lower dementia risk compared with placebo.

Mindfulness could lower elevated blood pressure

News - Nov. 7, 2022

AHA 2022 By participating in a mindfulness-based program, individuals with elevated office blood pressure (BP) could lower their systolic BP by 4.5 mmHg within 6 months compared with enhanced usual care.

Safely lowering of LDL-c with bempedoic acid in subgroups of patients

News - Apr. 19, 2022

ACC 2022 Two analyses using data of four phase 3 trials show that treatment with bempedoic acid lowers LDL-c in patients with renal impairment and in patients with hypertension. In addition, the analyses showed that bempedoic acid was generally well tolerated in these patients.

Adverse pregnancy outcomes reduced with treatment of chronic hypertension

3' education - Apr. 3, 2022 - Prof. Alan Tita, MD, PhD
Prof. Tita shares the results of the CHAP trial, which showed that treatment of mild chronic hypertension in pregnant women to a BP goal <140/90 mmHg reduces adverse pregnancy outcomes and does not impair fetal growth.

ACC 2022 Prof. Tita shares the results of the CHAP trial, which showed that treatment of mild chronic hypertension in pregnant women to a BP goal <140/90 mmHg reduces adverse pregnancy outcomes and does not impair fetal growth.